Listing items by Author "Martin Castillo, Begoña"

28 items found

Showing titles from 0 to 25:

  1  2   
FormatDateTitleAuthor
FormatDateTitleAuthor
doc icon DUGiDocs 2017 BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells Cuyàs, Elisabet ; Corominas Faja, Bruna ; Muñoz-San Martín, María ; Martin Castillo, Begoña ; Lupu, Ruth ; Brunet i Vidal, Joan ; Bosch Barrera, Joaquim ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2012 April Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts Cufí González, Sílvia ; Corominas Faja, Bruna ; Vázquez Martín, Alejandro ; Oliveras Ferrarós, Cristina ; Dorca Ribugent, Joan ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2014 Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
out url icon Recercat 2018 June 5 Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment Menéndez Menéndez, Javier Abel ; Quirantes Piné, Rosa ; Rodríguez Gallego, Esther ; Cufí González, Sílvia ; Corominas Faja, Bruna ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Segura Carretero, Antonio ; Joven, Jorge
doc icon DUGiDocs 2015 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2016 September 12 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2012 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
  1  2   

Subjects

Authors